Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
Journal of the National Cancer Center
|
July 22, 2024
The time-series behavior of systemic inflammation-immune status in predicting survival of locally advanced non-small cell lung cancer treated with chemoradiotherapy
Tao Zhang, Jianyang Wang, Daquan Wang, et al.
Eclinicalmedicine
|
April 18, 2025
Efficacy and safety of online adaptive magnetic resonance-guided fractionated stereotactic radiotherapy for brain metastases in non-small cell lung cancer (GASTO-1075): a single-arm, phase 2 trial
Shiyang Zheng, Shouliang Ding, Biaoshui Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 10, 2021
Comparison and quantification of different concurrent chemotherapy regimens with radiotherapy in locally advanced non-small cell lung cancer: Clinical outcomes and theoretical results from an extended LQ and TCP model
XinLei Ai, Bo Qiu, Yin Zhou, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 13, 2023
Patlak-Ki derived from ultra-high sensitivity dynamic total body [<sup>18</sup>F]FDG PET/CT correlates with the response to induction immuno-chemotherapy in locally advanced non-small cell lung cancer patients
DaQuan Wang, Bo Qiu, QianWen Liu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 16, 2021
Moderately Hypofractionated Once-Daily Compared With Twice-Daily Thoracic Radiation Therapy Concurrently With Etoposide and Cisplatin in Limited-Stage Small Cell Lung Cancer: A Multicenter, Phase II, Randomized Trial
Bo Qiu, QiWen Li, JunLing Liu, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 2, 2021
Hypo-fractionated radiotherapy with concurrent chemotherapy for locoregional recurrence of non-small cell lung cancer after complete resection: A prospective, single-arm, phase II study (GASTO-1017)
NaiBin Chen, QiWen Li, SiYu Wang, et al.
Radiation Oncology (London, England)
|
June 15, 2019
Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study
Daquan Wang, Nan Bi, Tao Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 8, 2021
A validation study on the lung immune prognostic index for prognostic value in patients with locally advanced non-small cell lung cancer
Tao Zhang, Wenji Xue, Daquan Wang, et al.
Signal Transduction and Targeted Therapy
|
September 28, 2025
Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial
Bo Qiu, Yuanyuan Zhao, Wenzhuo He, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
Journal of the National Cancer Center
|
July 22, 2024
The time-series behavior of systemic inflammation-immune status in predicting survival of locally advanced non-small cell lung cancer treated with chemoradiotherapy
Tao Zhang, Jianyang Wang, Daquan Wang, et al.
Eclinicalmedicine
|
April 18, 2025
Efficacy and safety of online adaptive magnetic resonance-guided fractionated stereotactic radiotherapy for brain metastases in non-small cell lung cancer (GASTO-1075): a single-arm, phase 2 trial
Shiyang Zheng, Shouliang Ding, Biaoshui Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 10, 2021
Comparison and quantification of different concurrent chemotherapy regimens with radiotherapy in locally advanced non-small cell lung cancer: Clinical outcomes and theoretical results from an extended LQ and TCP model
XinLei Ai, Bo Qiu, Yin Zhou, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 13, 2023
Patlak-Ki derived from ultra-high sensitivity dynamic total body [<sup>18</sup>F]FDG PET/CT correlates with the response to induction immuno-chemotherapy in locally advanced non-small cell lung cancer patients
DaQuan Wang, Bo Qiu, QianWen Liu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 16, 2021
Moderately Hypofractionated Once-Daily Compared With Twice-Daily Thoracic Radiation Therapy Concurrently With Etoposide and Cisplatin in Limited-Stage Small Cell Lung Cancer: A Multicenter, Phase II, Randomized Trial
Bo Qiu, QiWen Li, JunLing Liu, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 2, 2021
Hypo-fractionated radiotherapy with concurrent chemotherapy for locoregional recurrence of non-small cell lung cancer after complete resection: A prospective, single-arm, phase II study (GASTO-1017)
NaiBin Chen, QiWen Li, SiYu Wang, et al.
Radiation Oncology (London, England)
|
June 15, 2019
Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study
Daquan Wang, Nan Bi, Tao Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 8, 2021
A validation study on the lung immune prognostic index for prognostic value in patients with locally advanced non-small cell lung cancer
Tao Zhang, Wenji Xue, Daquan Wang, et al.
Signal Transduction and Targeted Therapy
|
September 28, 2025
Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial
Bo Qiu, Yuanyuan Zhao, Wenzhuo He, et al.
Page
of 9